Literature DB >> 9317158

Activation of phospholipase A2 by complement C5b-9 in glomerular epithelial cells.

M Panesar1, J Papillon, A J McTavish, A V Cybulsky.   

Abstract

In rat membranous nephropathy, C5b-9 induces glomerular epithelial cell (GEC) injury and proteinuria, which is partially mediated by eicosanoids. In cultured rat GEC, sublytic C5b-9 injures plasma membranes and releases arachidonic acid (AA) and eicosanoids, due to activation of phospholipase A2 (PLA2). To address mechanisms of PLA2 activation, GEC were stably transfected with cDNAs of wild-type cytosolic PLA2 (cPLA2-wt), or group II secretory PLA2, producing overexpression of PLA2 activity. Sublytic C5b-9 markedly increased free [3H]AA in cPLA2-wt-transfected GEC, but only trivial increases were evident in secretory PLA2-transfected, or neo (control) GEC. In cPLA2-wt-transfected GEC, reduction of extracellular free Ca2+ or down-regulation of protein kinase C inhibited [3H]AA release. To further address the regulation of cPLA2, we stably expressed a mutant cPLA2 in which the Ca2+-dependent lipid binding domain was deleted (deltaCaLB). In GEC that express cPLA2-deltaCaLB, the C5b-9-induced increase in free [3H]AA was comparable with neo, despite expression of cPLA2-deltaCaLB at levels similar to cPLA2-wt. We then stably expressed another cPLA2 mutant (cPLA2-srcmyr) in which the CaLB domain was replaced by the N-terminal myristoylation domain of c-Src. cPLA2-srcmyr is permanently membrane associated. At low extracellular free Ca2+, C5b-9 increased free [3H]AA significantly in GEC that express cPLA2-srcmyr, while in neo GEC, the change was negligible. Thus, C5b-9 activates the cPLA2 isoform. Activation is dependent on the CaLB domain, and is mediated by phosphorylation, Ca2+ influx, and membrane association.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9317158

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  11 in total

Review 1.  Experimental membranous nephropathy redux.

Authors:  Andrey V Cybulsky; Richard J Quigg; David J Salant
Journal:  Am J Physiol Renal Physiol       Date:  2005-10

2.  Cytolytic complement activity in otitis media with effusion.

Authors:  M Närkiö-Mäkelä; S Meri
Journal:  Clin Exp Immunol       Date:  2001-06       Impact factor: 4.330

3.  The Role of Phospholipase A(2)-derived Mediators in Obesity.

Authors:  Marcia J Abbott; Tianyi Tang; Hei Sook Sul
Journal:  Drug Discov Today Dis Mech       Date:  2010

4.  Complement C5b-9 induces receptor tyrosine kinase transactivation in glomerular epithelial cells.

Authors:  A V Cybulsky; T Takano; J Papillon; A J McTavish
Journal:  Am J Pathol       Date:  1999-11       Impact factor: 4.307

5.  Complement C5b-9-mediated arachidonic acid metabolism in glomerular epithelial cells : role of cyclooxygenase-1 and -2.

Authors:  T Takano; A V Cybulsky
Journal:  Am J Pathol       Date:  2000-06       Impact factor: 4.307

6.  Cytosolic phospholipase A2-alpha associates with plasma membrane, endoplasmic reticulum and nuclear membrane in glomerular epithelial cells.

Authors:  J Liu; T Takano; J Papillon; A Khadir; A V Cybulsky
Journal:  Biochem J       Date:  2001-01-01       Impact factor: 3.857

7.  Receptor-like protein tyrosine phosphatase alpha homodimerizes on the cell surface.

Authors:  G Jiang; J den Hertog; T Hunter
Journal:  Mol Cell Biol       Date:  2000-08       Impact factor: 4.272

8.  Complement-mediated activation of calcium-independent phospholipase A2γ: role of protein kinases and phosphorylation.

Authors:  Hanan Elimam; Joan Papillon; Tomoko Takano; Andrey V Cybulsky
Journal:  J Biol Chem       Date:  2012-12-20       Impact factor: 5.157

Review 9.  Podocyte dysfunction in atypical haemolytic uraemic syndrome.

Authors:  Marina Noris; Caterina Mele; Giuseppe Remuzzi
Journal:  Nat Rev Nephrol       Date:  2015-01-20       Impact factor: 28.314

10.  CD59a deficiency exacerbates ischemia-reperfusion injury in mice.

Authors:  Daniel Turnberg; Marina Botto; Margarita Lewis; Wuding Zhou; Steven H Sacks; B Paul Morgan; Mark J Walport; H Terence Cook
Journal:  Am J Pathol       Date:  2004-09       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.